ESTRO 2024 - Abstract Book

S2806

Interdisciplinary - Health economics & health services research

ESTRO 2024

Keywords: care pathway, patient journey, action research

References:

1. Jacobs M, Kerkmeijer L, de Ruysscher D, Brunenberg E, Boersma L, Verheij M. Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learned. Radiotherapy and Oncology. 2021;

2. Thijssen SV, Boersma LJ, Heising L, Swart RR, Ou CX, Roumen C, et al. Clues to address barriers for access to proton therapy in the Netherlands. Radiotherapy and Oncology. 2022;

3. Davison RM, Martinsons MG, Ou CX. The roles of theory in canonical action research. MIS Quarterly. 2012;763 – 86.

4. Peters VJ, Meijboom BR, Bunt JEH, Bok LA, van Steenbergen MW, de Winter JP, et al. Providing person centered care for patients with complex healthcare needs: A qualitative study. PLoS One. 2020;15(11):e0242418.

5. Khanna A, Fix GM, Anderson E, Bolton RE, Bokhour BG, Foster M, et al. Towards a framework for patient centred care coordination: a scoping review protocol. BMJ open. 2022;12(12):e066808.

6. Ahluwalia SC, Damberg CL, Silverman M, Motala A, Shekelle PG. What defines a high-performing health care delivery system: a systematic review. The Joint Commission Journal on Quality and Patient Safety. 2017;43(9):450 – 9.

1288

Digital Poster

Role of radiotherapy in cure of cancer of different tumour types – results from the FORTY project

Neil G Burnet 1 , Thomas Mee 1,2 , Norman F Kirkby 2 , Karen J Kirkby 2,1

1 The Christie NHS Foundation Trust, Proton Centre, Manchester, United Kingdom. 2 University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom

Purpose/Objective:

The FORTY (Favourable Outcomes from RadioTherapY) project has estimated that overall almost 40% of patients surviving 5 years have received radiotherapy (RT) [1]. This mirrors the 40% estimate from Tubiana in 1992, which has been widely quoted. This is an average figure across all patients with any cancer. Using comprehensive cancer and follow-up data gathered in NHS England, we have examined the role of RT for individual tumour types.

Material/Methods: